AAAAAA
Results:
1-11
|
Results: 11
Authors:
Leyland-Jones, B
Arnold, A
Gelmon, K
Verma, S
Ayoub, JP
Seidman, A
Dias, R
Howell, J
Rakhit, A
Citation: B. Leyland-jones et al., Pharmacologic insights into the future of trastuzumab, ANN ONCOL, 12, 2001, pp. 43-47
Authors:
Leyland-Jones, B
Citation: B. Leyland-jones, Dose scheduling - Herceptin (R), ONCOL-BASEL, 61, 2001, pp. 31-36
Authors:
Leyland-Jones, B
Smith, I
Citation: B. Leyland-jones et I. Smith, Role of Herceptin (R) in primary breast cancer: Views from North America and Europe, ONCOL-BASEL, 61, 2001, pp. 83-91
Authors:
Slamon, DJ
Leyland-Jones, B
Shak, S
Fuchs, H
Paton, V
Bajamonde, A
Fleming, T
Eiermann, W
Wolter, J
Pegram, M
Baselga, J
Norton, L
Citation: Dj. Slamon et al., Use of chemotherapy plus a monoclonal antibody against HER2 for metastaticbreast cancer that overexpresses HER2., N ENG J MED, 344(11), 2001, pp. 783-792
Authors:
Wong, P
Banerjee, K
Massengill, J
Nowell, S
Lang, N
Leyland-Jones, B
Citation: P. Wong et al., Validity of an ELISA for N-acetyltransferase-2 (NAT2) phenotyping, J IMMUNOL M, 251(1-2), 2001, pp. 1-9
Authors:
Trudeau, M
Seymour, R
Stanimir, G
Souhami, L
Arthur, L
Dulude, H
Gallant, G
Leyland-Jones, B
Citation: M. Trudeau et al., A phase II trial of mitomycin, ifosfamide and cisplatin in recurrent carcinoma of the cervix, INT J GYN C, 10(3), 2000, pp. 207-211
Authors:
Hiorns, LR
Seckl, MJ
Paradinas, F
Sharp, SY
Skelton, LA
Brunstrom, G
Newlands, ES
Kelland, LR
Leyland-Jones, B
Citation: Lr. Hiorns et al., A molecular cytogenetic approach to studying platinum resistance, J INORG BIO, 77(1-2), 1999, pp. 95-104
Authors:
Jean-Claude, BJ
Mustafa, A
Watson, AJ
Damian, Z
Vasilescu, D
Chan, TH
Leyland-Jones, B
Citation: Bj. Jean-claude et al., Tetrazepinones are equally cytotoxic to Mer+ and Mer- human tumor cell lines, J PHARM EXP, 288(2), 1999, pp. 484-489
Authors:
Leyland-Jones, B
Grieshaber, CK
Citation: B. Leyland-jones et Ck. Grieshaber, Of (only) mice and men, BR J CANC, 81(5), 1999, pp. 753-755
Authors:
Jean-Claude, BJ
Mustafa, A
Damian, Z
De Marte, J
Vasilescu, DE
Yen, R
Chan, TH
Leyland-Jones, B
Citation: Bj. Jean-claude et al., Cytokinetics of a novel 1,2,3-triazene-containing heterocycle, 8-nitro-3-methyl-benzo-1,2,3,5-tetrazepin-4(3H)-one (NIME), in the human epithelial ovarian cancer cell line OVCAR-3, BIOCH PHARM, 57(7), 1999, pp. 753-762
Authors:
Leyland-Jones, B
Kelland, LR
Harrap, KR
Hiorns, LR
Citation: B. Leyland-jones et al., Genomic imbalances associated with acquired resistance to platinum analogues, AM J PATH, 155(1), 1999, pp. 77-84
Risultati:
1-11
|